KRAS-G12C mutation is associated with poor outcome in surgically-resected lung adenocarcinoma

類似資料

• KRAS(G12C) Mutation Is Associated with Increased Risk of Recurrence in Surgically Resected Lung Adenocarcinoma
  著者:: Jones, Gregory D., 等
  出版事項: (2021)
• Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases
  著者:: Renaud, Stéphane, 等
  出版事項: (2015)
• KRAS G>A Mutation Favors Poor Tumor Differentiation but May Not be Associated with Prognosis in Patients with Curatively Resected Duodenal Adenocarcinoma
  著者:: Fu, Tao, 等
  出版事項: (2013)
• Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras(G12V) mice
  著者:: Kumar, Gaurav, 等
  出版事項: (2021)
• EGFR and KRAS mutation coexistence in lung adenocarcinomas
  著者:: Vitor Manuel Leitão de Sousa, 等
  出版事項: (2015-04-01)